from Health Economics at http://bit.ly/2fkfdNp on October 30, 2016 at 11:09AM We develop a structural model for bounding welfare effects of policies that alter the design of differentiated product markets when some consumers may be misinformed about product characteristics and inertia in consumer behavior reflects a mixture of latent preferences, information costs, switching costs and […]
from Health Economics at http://bit.ly/2f2JvAA on October 30, 2016 at 11:09AM We study the impact of targeted high quality preschool over the life cycle and across generations, and examine its interaction with a health intervention during infancy. Using administrative data from Denmark together with variation in the timing of program implementation between 1933 and 1960, […]
from Health Economics at http://bit.ly/2fk9FCq on October 30, 2016 at 11:09AM This paper examines the consequences of disability, identifying for the first time, the separate impacts of onsets and recoveries from disability on both employment status and hours worked using panel data from Indonesia. We find that changes in physical functioning have no affect hours […]
from THCB at http://bit.ly/2ebc5AE on October 30, 2016 at 07:22AM By NIRAN AL-AGBA,MD Should patients fire their doctors if they suspect burnout? In a recent PBS interview, Mayo Clinic CEO Dr. John Noseworthy suggested patients should “change physicians” when faced with non-empathetic doctors suffering from burnout. His cavalier resolution to our occupational struggle feels like […]
from THCB at http://bit.ly/2e1dkze on October 30, 2016 at 06:54AM Home Uncategorized MACRA and the New Quality Payment Program: Most Frequently Asked Questions MACRA and the New Quality Payment Program: Most Frequently Asked Questions November 2 | 2-3 PM EST / With THCB On Oct. 14 the Centers for Medicare and Medicaid Services (CMS) released […]
from Market Design at http://bit.ly/2f28cNl on October 30, 2016 at 05:29AM Solid organ donation gets more press, but tissue transplants and medical devices made from human tissue are big business. Here’s a profile of a Virginia organ and tissue bank:Hearts, lungs and kidneys recovered by LifeNet Health get the most attention, but tissue is the […]
from Google Alert at http://bit.ly/2e02Yj3 on October 30, 2016 at 01:42AM I AM IN THE (IHSR) HEALTH ECONOMICS DEPARTMENT. In health economics, we study about the economics of health – how can we finance health, …
from Google Alert at http://bit.ly/2eUTObX on October 29, 2016 at 09:48PM I AM IN THE (IHSR) HEALTH ECONOMICS DEPARTMENT. In health economics, we study about the economics of health – how can we finance health, …
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2e89J5A on October 29, 2016 at 08:11AM The full agenda is now available for the 2nd Panel on CEA conference (available below). This one-day conference on December 7, 2016 at the National Academy of Sciences in Washington DC will highlight the Recommendations of the Second Panel on Cost-Effectiveness […]
from The Incidental Economist at http://bit.ly/2eXWxQd on October 29, 2016 at 07:13AM Healthcare Triage News: Lots of Private Insurance is Publicly Funded Every time health care reform comes up for debate, I see people arguing about whether a publicly or privately funded system would be better. The Affordable Care Act, in an attempt to forestall […]
from Market Design at http://bit.ly/2e7RLQI on October 29, 2016 at 06:05AM Here’s an early, optimistic report:Organ donation rates have risen since the ‘opt-out’ system was introduced in Wales "There has been a rise in the number of organs being donated by people in Wales since the new “opt out” law was put in place last […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2fpjTRt on October 28, 2016 at 10:09PM Only in recent years have people in the pharmaceutical industry realized just how beneficial using Real World Evidence could be. Read more here. (Source: PharmaTimes, November 2016)
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2dVHd3L on October 28, 2016 at 10:09PM Real world evidence offers big potential to get medicines to the market, but exploiting the data is not always easy for companies. Pfizer’s James Harnett explains the firm’s RWE strategy and some of the challenges, like unstructured data and the need […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2dVCgs0 on October 28, 2016 at 09:39PM According to a recent tracking poll from the Kaiser Family Foundation, U.S. voters are wanting the next president and Congress to do something about prescription drug prices more than the want the health law changed. Find out more here. (Source: Julie […]
from Google Alert at http://bit.ly/2dUwFSD on October 28, 2016 at 01:42PM I hope you’re fine,. For our Life Science client in Zug, we are seeking a Sr. Health Economics Manager,. Start Date: ASAP. End Date: November 2017.
from Google Alert at http://bit.ly/2ejtDbt on October 28, 2016 at 12:18PM “The SAFE strategy is cost–effective and affordable” added Christopher Fitzpatrick, Health Economist at the Department of Control of Neglected …
from Google Alert at http://bit.ly/2eDHJaL on October 28, 2016 at 10:42AM help develop and deliver training and teaching in health economics and related topics for GBHI in conjunction with colleagues across the School of …
from THCB at http://bit.ly/2fmZZq4 on October 28, 2016 at 07:37AM By STEVEN FINDLAY OK. Yes, this is bad. The Obama administration is being disingenuous if it tries to spin it any other way. And, as has been clear for several months, this hands Hillary a “nasty” issue (pun intended). The “this,” of course, is the […]
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2fe2xaN on October 28, 2016 at 07:31AM Winter Edition of HEDS Newsletter Autumn is shaping up quite nicely, the leaves have turned golden brown, there is a crispness in the morning air and we are already looking forward to nights in front of the fire […]
from Market Design at http://bit.ly/2fmJSJf on October 28, 2016 at 06:44AM Market Design Working Group Meeting Michael Ostrovsky and Parag Pathak, Organizers October 28-29, 2016 SIEPRKoret-Taube Conference CenterStanford University366 Galvez StreetStanford, CA Program Participant List Friday, October 28 8:30 am Continental Breakfast 9:00 am Darrell Duffie, Stanford University and NBERHaoxiang Zhu, Massachusetts Institute of Technology and NBERSize Discovery […]
from The Incidental Economist at http://bit.ly/2eCSOsA on October 28, 2016 at 06:33AM JAMA: Importance Bacteriuria plus pyuria is highly prevalent among older women living in nursing homes. Cranberry capsules are an understudied, nonantimicrobial prevention strategy used in this population. Objective To test the effect of 2 oral cranberry capsules once a day on presence of […]
from The Incidental Economist at http://bit.ly/2fdRcrb on October 28, 2016 at 06:03AM In the NEJM, Lisa Rosenbaum writes about the shortened lives of the mentally ill. She takes her fellow physicians to task for neglecting these patients by allowing them to refuse needed medical care. It’s an important essay — go read it. I want to add, though, that doctors […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eMaNue on October 28, 2016 at 05:35AM Regardless of the outcomes in November’s Election process, the next U.S. Congress and administration is going to need to come together with some bipartisan collaboration to address several key issues affecting U.S. health care policy. What might this look like? Take […]
from Google Alert at http://bit.ly/2eClbqH on October 28, 2016 at 03:18AM Glenn Melnick, a professor and health economist at the University of Southern California, said his research shows Sutter Health has a huge stake in …
from Actualités at http://bit.ly/2eWxSuG on October 28, 2016 at 02:39AM Les membres du CES sont convoqués à une Assemblée générale extraordinaire pour renouveller les membres du Conseil d’Administration : plus d’informations
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2eWs3h6 on October 28, 2016 at 02:00AM Andy Tattersall Claire Beecroft Andy Tattersall and Claire Beecroft are running a one day workshop in Sheffield – An Introduction to using Social Media to Communicate Research. The workshop aims to give academics and aligned professionals a comprehensive […]
from Google Alert at http://bit.ly/2eYbG29 on October 28, 2016 at 01:42AM Freelance Health Economics Writer/Editor ! Miejsce pracy: Switzerland. Nr ref: 956933796Switzerland/jobs.pl. – Hands-on leadership of projects …
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2dNGPcr on October 27, 2016 at 11:34PM This HMRI Seminar series featured internationally recognized expert in comparative effectiveness research (CER), professor Francesco Chiappelli. Available to view here. (Source: YouTube, 10/11/16)
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2ehfonz on October 27, 2016 at 11:34PM Optum’s® comprehensive, integrated data helps life sciences companies better identify, understand and address the priorities of patients and providers, as well as regulators and payers. This is critical, given the health system’s continued transition to value-based care. Available for download here. (Source: Optum, […]
from Healthcare Economist at http://bit.ly/2dNEWwi on October 27, 2016 at 11:01PM Rising drug prices. QPP. Healthcare-wide CER. The age of tech. AI and medicine.
from Google Alert at http://bit.ly/2fli1c6 on October 27, 2016 at 09:15PM Singulex has an opening for a Health Economist in Alameda, CA.
from Health Economics at http://bit.ly/2egOyvZ on October 27, 2016 at 08:57PM Abstract Health state valuations of patients and non-patients are not the same, whereas health state values obtained from general population samples are a weighted average of both. The latter constitutes an often-overlooked source of bias. This study investigates the resulting bias and tests for […]
from Google Alert at http://bit.ly/2eLX7Cm on October 27, 2016 at 07:42PM … she was a research manager in the University’s Biological Sciences Division, focused on health economics research in oncology and rare diseases.
from THCB at http://bit.ly/2eAGRU6 on October 27, 2016 at 03:41PM By SAURABH JHA MD If you’re going to indulge in anticipatory medicine, it is best to anticipate those at highest risk. An elegant study by Wald et al in the NEJM shows how precision primary prevention can be done. The researchers screened toddlers, who […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eRDsyR on October 27, 2016 at 02:33PM POLITICO has recently learned that the pharmaceutical lobby has hiked membership dues 50% as the industry readies for a post-election battle over drug prices. This will give the group more than $300 million per year to fight possible legislative action. Read […]
from Google Alert at http://bit.ly/2dQ5bNN on October 27, 2016 at 01:42PM AstraZeneca Pharmaceuticals LP has an opening for a Executive Director, Health Economics and Outcomes Research in Gaithersburg, MD.
from Google Alert at http://bit.ly/2fkcQcx on October 27, 2016 at 01:42PM The global gender gap index ranks 144 countries on the gap between women and men in four areas: health, economics, education, and politics.
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eKkXvi on October 27, 2016 at 01:33PM Halloween is not just for kids! Us adults are love to dress up and have a fun time as well. For all of you social media marketers out their, why not come to work in something really special this Halloween? You […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2eL0f1a on October 27, 2016 at 01:33PM HEOR Medical Communications Professionals Demonstrating Healthcare Value and Achieving Market Access Through Publication: This group addresses the rapidly-expanding need for qualified medical communications professionals or researchers who create communications tools that demonstrate product value, achieve market access, and address the […]
from CEA Registry Team at http://bit.ly/2eKQBeZ on October 27, 2016 at 01:14PM Research suggests that private health care payers cover medical interventions inconsistently. In a study published in the Journal of Managed Care and Specialty Pharmacy we examined the consistency of the largest private payers’ coverage decisions for rheumatoid arthritis drugs.3 We examined coverage policies for rheumatoid […]